Antibody response to BNT162b2 SARS-CoV-2 mRNA vaccine is not influenced by AB0 blood group in subjects with transfusion-dependent thalassemia.

Sgherza, Nicola; Zucano, Stefania; Vitucci, Angelantonio; Palma, Antonio; Campanale, Daniela; Larocca, Angela Maria Vittoria; Visceglie, Domenico; Acquafredda, Amalia; Musto, Pellegrino

Sgherza, Nicola; Zucano, Stefania; Vitucci, Angelantonio; Palma, Antonio; Campanale, Daniela; Larocca, Angela Maria Vittoria; Visceglie, Domenico; Acquafredda, Amalia; Musto, Pellegrino.

Sgherza N; a:1:{s:5:"en_US";s:147:"Hematology and Bone Marrow Transplantation Unit - AOUC Policlinico, Department of Emergency and Organ Transplantation, "Aldo Moro" University, Bari";}. nicolasgherza@libero.it.
Zucano S; . nicolasgherza@libero.it.
Vitucci A; . nicolasgherza@libero.it.
Palma A; . nioclasgherza@libero.it.
Campanale D; . nicolasgherza@libero.it.
Larocca AMV; . nicolasgherza@libero.it.
Visceglie D; . nicolasgherza@libero.it.
Acquafredda A; . nicolasgherza@libero.it.
Musto P; . pellegrino.musto@uniba.it.

Acta Biomed ; 93(2): e2022134, 2022 05 11.

Article in English | MEDLINE | ID: covidwho-1848014

ABSTRACT

ABSTRACT

Not applicable.

Subject(s)

Blood Group Antigens; COVID-19; Thalassemia; Antibodies, Viral; Antibody Formation; BNT162 Vaccine; COVID-19/prevention & control; COVID-19 Vaccines; Humans; SARS-CoV-2; Thalassemia/genetics; Thalassemia/therapy; Vaccines, Synthetic; mRNA Vaccines

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Thalassemia / Blood Group Antigens / COVID-19 Type of study: Randomized controlled trials Topics: Vaccines Limits: Humans Language: English Journal: Acta Biomed Journal subject: Medicine Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google